Nanobiotix SA (NBTX)
Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical nee...
- Open
- 43.110
- High
- 44.850
- Low
- 43.110
- Prev. Close
- 43.680
- Volume
- 74.31K
- Turnover
- 3.26M
- Avg Price
- 43.818
- Bid/Ask Ratio
- --
- Amplitude
- 3.98%
- 52wk High
- 57.140
- Volume Ratio
- 0.60
- Turnover Ratio
- 0.24%
Nanobiotix SA Analyst Rating
View moreForecast & Rating
Jul 22, 2026Price forecast
$44.532.24%
Forecast & RatingStrong buy
5analysts
- Strong buy80.00%
- Buy0.00%
- Hold20.00%
- Sell0.00%
- Strong sell0.00%
News
- benzinga_article · Aug 17 at 12:06 PM
12 Health Care Stocks Moving In Monday's Intraday Session
- PUBT · Jul 30 at 03:20 PM
Nanobiotix reports 50,825,682 shares outstanding, 54,464,772 exercisable voting rights as of June 30, 2026
- TradingView · Jul 10 at 08:20 AM
Nanobiotix S.A. Stock 12‑Month Price Target Raised to $54.34, Implies 40% Upside
- PUBT · Jul 7 at 08:41 AM
Qube Research & Technologies discloses net short position in Nanobiotix
- PUBT · Jul 6 at 10:11 AM
Goldman Sachs cuts Nanobiotix stake below 5% threshold, AMF filing shows
- PUBT · Jul 1 at 08:56 AM
Qube Research & Technologies discloses net short position in Nanobiotix shares
